NeuroBo Pharmaceuticals, Inc

-$0.0583 (-10.32%) Today
$0.00 (0.00%) As of 8:58 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRBO and other ETFs, options, and stocks.

About NRBO

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.

CEO
Ben Gil Price
Employees
11
Headquarters
Boston, Massachusetts
Founded
2014

NRBO Key Statistics

Market cap
13.63M
Price-Earnings ratio
—
Dividend yield
—
Average volume
158.05K
High today
$0.59
Low today
$0.495
Open price
$0.54
Volume
187.63K
52 Week high
$6.57
52 Week low
$0.4134

NRBO Earnings

-$1.20
-$0.80
-$0.40
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Jun 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure